8 found
Order:
  1.  29
    Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust. [REVIEW]Matthew Herder & Jennifer Dyck Brian - 2008 - Journal of Business Ethics 77 (1):73 - 84.
    This paper examines one nascent entrepreneurial endeavour intended by Canada's Stem Cell Network to catalyze the commercialization of stem cell research: the creation of a company called "Aggregate Therapeutics". We argue that this initiative, in its current configuration, is likely to result in a breach of public trust owing to three inter-related concerns: conflicts of interest; corporate influence on the university research agenda; and the failure to provide some form of direct return for the public's substantial tax dollar investment. These (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  2.  6
    Canada’s Stem Cell Corporation: Aggregate Concerns and the Question of Public Trust.Matthew Herder & Jennifer Dyck Brian - 2008 - Journal of Business Ethics 77 (1):73-84.
    This paper examines one nascent entrepreneurial endeavour intended by Canada's Stem Cell Network to catalyze the commercialization of stem cell research: the creation of a company called "Aggregate Therapeutics". We argue that this initiative, in its current configuration, is likely to result in a breach of public trust owing to three inter-related concerns: conflicts of interest; corporate influence on the university research agenda; and the failure to provide some form of direct return for the public's substantial tax dollar investment. These (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  3.  95
    Justice in Global Pandemic Influenza Preparedness: An Analysis Based on the Values of Contribution, Ownership and Reciprocity.Meena Krishnamurthy & Matthew Herder - 2013 - Public Health Ethics (3):pht027.
    In December 2006, Indonesia decided to stop sending influenza virus specimens to the World Health Organization’s Global Influenza Surveillance Network (GISN). Indonesia justified its actions by claiming that they were in protest of the injustice of GISN. Its actions stimulated negotiations to improve the workings of GISN by developing and implementing a more just framework for ‘sharing influenza viruses and other benefits’. These negotiations eventually led to the adoption of a new framework for virus and benefit sharing in May 2011, (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  47
    Policy Design for Human Embryo Research in Canada: A History (Part 1 of 2). [REVIEW]Françoise Baylis & Matthew Herder - 2009 - Journal of Bioethical Inquiry 6 (1):109-122.
    This article is the first in a two-part review of policy design for human embryo research in Canada. In this article we explain how this area of research is circumscribed by law promulgated by the federal Parliament (the Assisted Human Reproduction Act ) and by guidelines issued by the Tri-Agencies (the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans and Updated Guidelines for Human Pluripotent Stem Cell Research ). In so doing, we provide the first comprehensive account of the (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  35
    Proliferating Patent Problems with Human Embryonic Stem Cell Research?Matthew Herder - 2006 - Journal of Bioethical Inquiry 3 (1-2):69-79.
    The scientific challenges and ethical controversies facing human embryonic stem cell (hESC) research continue to command attention. The issues posed by patenting hESC technologies have, however, largely failed to penetrate the discourse, much less result in political action. This paper examines U.S. and European patent systems, illustrating discrepancies in the patentability of hESC technologies and identifying potential negative consequences associated with efforts to make available hESC research tools for basic research purposes while at same time strengthening the position of certain (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  6.  34
    Policy Design for Human Embryo Research in Canada: An Analysis (Part 2 of 2). [REVIEW]Françoise Baylis & Matthew Herder - 2009 - Journal of Bioethical Inquiry 6 (3):351-365.
    This article is the second in a two-part review of policy design for human embryo research in Canada. In the first article in 6(1) of the JBI , we explain how this area of research is circumscribed by law promulgated by the federal Parliament and by guidelines adopted by the Tri-Agencies, and we provide a chronological description of relevant policy initiatives and outcomes related to these two policy instruments, with particular attention to the repeated efforts at public consultation. This second (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark  
  7.  14
    Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.
    Efforts to foster transparency in biopharmaceutical regulation are well underway: drug manufacturers are, for example, legally required to register clinical trials and share research results in the United States and Europe. Recently, the policy conversation has shifted toward the disclosure of clinical trial data, not just trial designs and basic results. Here, I argue that clinical trial registration and disclosure of clinical trial data are necessary but insufficient. There is also a need to ensure that regulatory decisions that flow from (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  8.  6
    Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark